The correlation of HIGD2A high expression and poor patient survival is significant for liver hepatocellular carcinoma, skin cutaneous melanoma, uterine corpus endometrial carcinoma, and uveal melanoma. This evidence concerns the gene HIGD2A and uveal melanoma.